BERKELEY, Calif.--(BUSINESS WIRE)--Nov 1, 2023--IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today announced a collaboration through a know-how agreement with Mayo Clinic to develop AI designed to significantly improve the analysis and understanding of ...
PETERSBURG, Va.--(BUSINESS WIRE)--Nov 1, 2023--Civica Inc. (Civica, Civica Rx) is proud to announce that pharmaceutical industry leader Bouwien Smits has joined Civica as the new Site Vice President and General Manager of the companyÄ¢¹½ÊÓÆµ new sterile injectable manufacturing facility.Smits has ...
JERSEY CITY, N.J. & SAN FRANCISCO--(BUSINESS WIRE)--Nov 1, 2023--Organon (NYSE:OGN) and Sempre Health today announced a strategic partnership designed to motivate eligible patients to refill their prescriptions on time and improve adherence through an innovative pricing program that ...
TORONTO--(BUSINESS WIRE)--Nov 1, 2023--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen sulfide platform to develop next-generation therapies targeting pain and inflammation, is pleased to announce the completion of the ...